Artiva Biotherapeutics, Inc.'s total assets for Q2 2025 were $169.39M, a decrease of -11.44% from the previous quarter. ARTV total liabilities were $20.35M for the fiscal quarter, a -9.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.